Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 1
1975 1
1980 1
1981 1
1986 1
1987 2
1989 5
1990 1
1991 1
1992 1
1994 2
1996 1
1998 1
1999 2
2000 2
2001 2
2002 2
2003 2
2004 2
2008 2
2009 2
2010 3
2011 2
2012 1
2013 2
2014 3
2015 4
2016 3
2017 1
2018 4
2019 6
2020 9
2021 8
2022 9
2023 7
2024 4
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
Acne vulgaris.
Brown SK, Shalita AR. Brown SK, et al. Lancet. 1998 Jun 20;351(9119):1871-6. doi: 10.1016/S0140-6736(98)01046-0. Lancet. 1998. PMID: 9652685 Review. No abstract available.
Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.
Hussain S, Meijer A, Govorkova EA, Dapat C, Gubareva LV, Barr IG, Brown SK, Daniels RS, Fujisaki S, Galiano M, Huang W, Kondor RJ, Lackenby A, Lewis N, Lo J, Nguyen HT, Patel MC, Pereyaslov D, Rattigan A, Samaan M, Wang D, Webby RJ, Yen HL, Zhang W, Takashita E. Hussain S, et al. Among authors: brown sk. Antiviral Res. 2025 Sep;241:106217. doi: 10.1016/j.antiviral.2025.106217. Epub 2025 Jun 24. Antiviral Res. 2025. PMID: 40571063 Free PMC article.
Safety and immunogenicity of a delayed booster dose of the rVSVΔG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial.
Davey RT Jr, Collins GL, Rouphael N, Poliquin G, McConnell R, Grubbs G, Moir SL, Langley JM, Teitelbaum M, Hewlett AL, McLellan SLF, Bhadelia N, Raabe VN, Mulligan MJ, Maljkovic Berry I, Dighero-Kemp B, Kurtz JR, Hensley LE, Dozier NCE, Marron LCB, DuChene A, Kuhn JH, Brown SK, Khurana S, Lane HC, Neaton JD. Davey RT Jr, et al. Among authors: brown sk. Lancet Microbe. 2024 Nov;5(11):100923. doi: 10.1016/S2666-5247(24)00163-0. Epub 2024 Oct 4. Lancet Microbe. 2024. PMID: 39374605 Free PMC article. Clinical Trial.
Multiple models for Rosaceae genomics.
Shulaev V, Korban SS, Sosinski B, Abbott AG, Aldwinckle HS, Folta KM, Iezzoni A, Main D, Arús P, Dandekar AM, Lewers K, Brown SK, Davis TM, Gardiner SE, Potter D, Veilleux RE. Shulaev V, et al. Among authors: brown sk. Plant Physiol. 2008 Jul;147(3):985-1003. doi: 10.1104/pp.107.115618. Epub 2008 May 16. Plant Physiol. 2008. PMID: 18487361 Free PMC article. Review.
Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020.
Govorkova EA, Takashita E, Daniels RS, Fujisaki S, Presser LD, Patel MC, Huang W, Lackenby A, Nguyen HT, Pereyaslov D, Rattigan A, Brown SK, Samaan M, Subbarao K, Wong S, Wang D, Webby RJ, Yen HL, Zhang W, Meijer A, Gubareva LV. Govorkova EA, et al. Among authors: brown sk. Antiviral Res. 2022 Apr;200:105281. doi: 10.1016/j.antiviral.2022.105281. Epub 2022 Mar 12. Antiviral Res. 2022. PMID: 35292289 Free PMC article. Review.
94 results